Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Loa Loa (eye worm) | hypothetical protein | 0.0199 | 0.8608 | 0.8608 |
Loa Loa (eye worm) | hypothetical protein | 0.0123 | 0.5183 | 0.5183 |
Schistosoma mansoni | neuroligin 3 (S09 family) | 0.0034 | 0.1201 | 0.1395 |
Echinococcus multilocularis | family S9 non peptidase ue (S09 family) | 0.0034 | 0.1201 | 0.1201 |
Onchocerca volvulus | 0.0034 | 0.1201 | 0.6684 | |
Entamoeba histolytica | hypothetical protein | 0.0035 | 0.1249 | 1 |
Trypanosoma brucei | PAB1-binding protein , putative | 0.0025 | 0.0801 | 0.1545 |
Loa Loa (eye worm) | hypothetical protein | 0.0034 | 0.1201 | 0.1201 |
Echinococcus granulosus | diuretic hormone 44 receptor GPRdih2 | 0.0015 | 0.0387 | 0.0387 |
Mycobacterium tuberculosis | Carboxylesterase LipT | 0.0034 | 0.1201 | 1 |
Loa Loa (eye worm) | latrophilin receptor protein 2 | 0.0015 | 0.0387 | 0.0387 |
Toxoplasma gondii | ATPase/histidine kinase/DNA gyrase B/HSP90 domain-containing protein | 0.005 | 0.1919 | 0.9379 |
Brugia malayi | Corticotropin releasing factor receptor 2 precursor, putative | 0.0049 | 0.1882 | 0.1882 |
Plasmodium vivax | ataxin-2 like protein, putative | 0.0025 | 0.0801 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0034 | 0.1201 | 0.1201 |
Loa Loa (eye worm) | hypothetical protein | 0.0015 | 0.0387 | 0.0387 |
Loa Loa (eye worm) | histone methyltransferase | 0.0009 | 0.0079 | 0.0079 |
Echinococcus multilocularis | carboxylesterase 5A | 0.0199 | 0.8608 | 0.8608 |
Echinococcus multilocularis | acetylcholinesterase | 0.0199 | 0.8608 | 0.8608 |
Mycobacterium ulcerans | carboxylesterase, LipT | 0.0034 | 0.1201 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0034 | 0.1201 | 0.1201 |
Echinococcus multilocularis | Pyruvate dehydrogenase (lipoamide) kinase | 0.0123 | 0.5183 | 0.5183 |
Brugia malayi | Carboxylesterase family protein | 0.0199 | 0.8608 | 0.8608 |
Loa Loa (eye worm) | hypothetical protein | 0.0034 | 0.1201 | 0.1201 |
Schistosoma mansoni | cpg binding protein | 0.0029 | 0.1006 | 0.1169 |
Echinococcus granulosus | para nitrobenzyl esterase | 0.0034 | 0.1201 | 0.1201 |
Toxoplasma gondii | histone lysine methyltransferase SET1 | 0.0053 | 0.2046 | 1 |
Trypanosoma cruzi | pyruvate dehydrogenase (lipoamide) kinase, putative | 0.0043 | 0.1614 | 0.3113 |
Loa Loa (eye worm) | hypothetical protein | 0.0033 | 0.119 | 0.119 |
Echinococcus multilocularis | Basic leucine zipper (bZIP) transcription | 0.0035 | 0.1249 | 0.1249 |
Echinococcus granulosus | BC026374 protein S09 family | 0.0034 | 0.1201 | 0.1201 |
Loa Loa (eye worm) | hypothetical protein | 0.0034 | 0.1201 | 0.1201 |
Schistosoma mansoni | family S9 non-peptidase homologue (S09 family) | 0.0199 | 0.8608 | 1 |
Echinococcus granulosus | cpg binding protein | 0.0029 | 0.1006 | 0.1006 |
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.0049 | 0.1882 | 0.1882 |
Echinococcus multilocularis | Pyruvate dehydrogenase (lipoamide) kinase | 0.0123 | 0.5183 | 0.5183 |
Brugia malayi | CXXC zinc finger family protein | 0.0028 | 0.0936 | 0.0936 |
Mycobacterium tuberculosis | POSSIBLE PARA-NITROBENZYL ESTERASE (FRAGMENT) | 0.0034 | 0.1201 | 1 |
Toxoplasma gondii | pyruvate dehydrogenase kinase, putative | 0.0043 | 0.1614 | 0.7887 |
Entamoeba histolytica | hypothetical protein | 0.0035 | 0.1249 | 1 |
Brugia malayi | Iron-sulfur cluster assembly accessory protein | 0.0047 | 0.1797 | 0.1797 |
Brugia malayi | hypothetical protein | 0.0016 | 0.0409 | 0.0409 |
Trypanosoma brucei | pyruvate dehydrogenase (lipoamide) kinase, putative | 0.0043 | 0.1614 | 0.3113 |
Loa Loa (eye worm) | hypothetical protein | 0.0034 | 0.1201 | 0.1201 |
Loa Loa (eye worm) | hypothetical protein | 0.0034 | 0.1201 | 0.1201 |
Echinococcus granulosus | mixed lineage leukemia protein mll | 0.0007 | 0.0003 | 0.0003 |
Schistosoma mansoni | family S9 non-peptidase homologue (S09 family) | 0.0034 | 0.1201 | 0.1395 |
Brugia malayi | Carboxylesterase family protein | 0.0034 | 0.1201 | 0.1201 |
Schistosoma mansoni | survival motor neuron protein | 0.0047 | 0.1797 | 0.2087 |
Schistosoma mansoni | hypothetical protein | 0.0015 | 0.0387 | 0.0449 |
Schistosoma mansoni | hypothetical protein | 0.0015 | 0.0387 | 0.0449 |
Echinococcus multilocularis | diuretic hormone 44 receptor GPRdih2 | 0.0015 | 0.0387 | 0.0387 |
Echinococcus granulosus | GPCR family 2 | 0.0015 | 0.0387 | 0.0387 |
Trypanosoma brucei | developmentally regulated phosphoprotein | 0.0123 | 0.5183 | 1 |
Loa Loa (eye worm) | acetylcholinesterase 1 | 0.0199 | 0.8608 | 0.8608 |
Schistosoma mansoni | hypothetical protein | 0.0015 | 0.0387 | 0.0449 |
Brugia malayi | F/Y-rich N-terminus family protein | 0.0008 | 0.0074 | 0.0074 |
Schistosoma mansoni | family S9 non-peptidase homologue (S09 family) | 0.0034 | 0.1201 | 0.1395 |
Toxoplasma gondii | LsmAD domain-containing protein | 0.0025 | 0.0801 | 0.3915 |
Schistosoma mansoni | hypothetical protein | 0.0033 | 0.119 | 0.1383 |
Schistosoma mansoni | family S9 non-peptidase homologue (S09 family) | 0.0034 | 0.1201 | 0.1395 |
Schistosoma mansoni | acetylcholinesterase | 0.0034 | 0.1201 | 0.1395 |
Trypanosoma cruzi | PAB1-binding protein , putative | 0.0025 | 0.0801 | 0.1545 |
Trypanosoma cruzi | developmentally regulated phosphoprotein, putative | 0.0123 | 0.5183 | 1 |
Echinococcus granulosus | Ataxin 2 N terminaldomain containing protein | 0.0011 | 0.0191 | 0.0191 |
Schistosoma mansoni | hypothetical protein | 0.0035 | 0.1249 | 0.1451 |
Echinococcus granulosus | carboxylesterase 5A | 0.0199 | 0.8608 | 0.8608 |
Onchocerca volvulus | 0.0028 | 0.0936 | 0.5208 | |
Brugia malayi | Carboxylesterase family protein | 0.0034 | 0.1201 | 0.1201 |
Schistosoma mansoni | mixed-lineage leukemia protein mll | 0.0007 | 0.0003 | 0.0003 |
Loa Loa (eye worm) | hypothetical protein | 0.0199 | 0.8608 | 0.8608 |
Loa Loa (eye worm) | carboxylesterase | 0.0199 | 0.8608 | 0.8608 |
Echinococcus multilocularis | mixed lineage leukemia protein mll | 0.0007 | 0.0003 | 0.0003 |
Echinococcus multilocularis | histone lysine N methyltransferase MLL3 | 0.0007 | 0.0003 | 0.0003 |
Trichomonas vaginalis | spcc417.12 protein, putative | 0.0034 | 0.1201 | 1 |
Loa Loa (eye worm) | carboxylesterase | 0.0034 | 0.1201 | 0.1201 |
Echinococcus multilocularis | cadherin EGF LAG seven pass G type receptor | 0.0015 | 0.0387 | 0.0387 |
Schistosoma mansoni | transcription factor LCR-F1 | 0.0035 | 0.1249 | 0.1451 |
Brugia malayi | Carboxylesterase family protein | 0.0199 | 0.8608 | 0.8608 |
Brugia malayi | Carboxylesterase family protein | 0.0034 | 0.1201 | 0.1201 |
Brugia malayi | hypothetical protein | 0.0034 | 0.1201 | 0.1201 |
Schistosoma mansoni | mixed-lineage leukemia protein mll | 0.0059 | 0.2327 | 0.2703 |
Echinococcus granulosus | acetylcholinesterase | 0.0199 | 0.8608 | 0.8608 |
Brugia malayi | latrophilin 2 splice variant baaae | 0.0033 | 0.119 | 0.119 |
Leishmania major | developmentally regulated phosphoprotein-like protein | 0.0123 | 0.5183 | 1 |
Schistosoma mansoni | cpg binding protein | 0.0029 | 0.1006 | 0.1169 |
Schistosoma mansoni | pyruvate dehydrogenase | 0.0123 | 0.5183 | 0.6021 |
Plasmodium falciparum | ataxin-2 like protein, putative | 0.0025 | 0.0801 | 1 |
Echinococcus granulosus | acetylcholinesterase | 0.0199 | 0.8608 | 0.8608 |
Brugia malayi | calcium-independent alpha-latrotoxin receptor 2, putative | 0.0015 | 0.0387 | 0.0387 |
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.0049 | 0.1882 | 0.1882 |
Schistosoma mansoni | cpg binding protein | 0.0028 | 0.0936 | 0.1087 |
Plasmodium falciparum | ataxin-2 like protein, putative | 0.0025 | 0.0801 | 1 |
Echinococcus multilocularis | para nitrobenzyl esterase | 0.0034 | 0.1201 | 0.1201 |
Echinococcus granulosus | family S9 non peptidase ue S09 family | 0.0034 | 0.1201 | 0.1201 |
Brugia malayi | Latrophilin receptor protein 2 | 0.0015 | 0.0387 | 0.0387 |
Echinococcus multilocularis | acetylcholinesterase | 0.0199 | 0.8608 | 0.8608 |
Schistosoma mansoni | hypothetical protein | 0.0015 | 0.0387 | 0.0449 |
Onchocerca volvulus | 0.0034 | 0.1201 | 0.6684 | |
Brugia malayi | Carboxylesterase family protein | 0.0034 | 0.1201 | 0.1201 |
Schistosoma mansoni | gliotactin | 0.0034 | 0.1201 | 0.1395 |
Entamoeba histolytica | hypothetical protein | 0.0035 | 0.1249 | 1 |
Leishmania major | hypothetical protein, conserved | 0.0025 | 0.0801 | 0.1545 |
Mycobacterium tuberculosis | POSSIBLE PARA-NITROBENZYL ESTERASE (FRAGMENT) | 0.0034 | 0.1201 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0025 | 0.0801 | 0.0801 |
Trypanosoma cruzi | PAB1-binding protein , putative | 0.0025 | 0.0801 | 0.1545 |
Schistosoma mansoni | hypothetical protein | 0.0047 | 0.1797 | 0.2087 |
Onchocerca volvulus | 0.0034 | 0.1201 | 0.6684 | |
Schistosoma mansoni | BC026374 protein (S09 family) | 0.0034 | 0.1201 | 0.1395 |
Loa Loa (eye worm) | hypothetical protein | 0.0049 | 0.1882 | 0.1882 |
Schistosoma mansoni | hypothetical protein | 0.0011 | 0.0191 | 0.0222 |
Echinococcus multilocularis | neuroligin | 0.0034 | 0.1201 | 0.1201 |
Echinococcus multilocularis | GPCR, family 2 | 0.0015 | 0.0387 | 0.0387 |
Onchocerca volvulus | 0.0047 | 0.1797 | 1 | |
Echinococcus granulosus | Basic leucine zipper bZIP transcription | 0.0035 | 0.1249 | 0.1249 |
Echinococcus granulosus | neuroligin | 0.0034 | 0.1201 | 0.1201 |
Onchocerca volvulus | 0.0034 | 0.1201 | 0.6684 | |
Echinococcus granulosus | histone lysine N methyltransferase MLL3 | 0.0009 | 0.0079 | 0.0079 |
Brugia malayi | hypothetical protein | 0.0035 | 0.1249 | 0.1249 |
Onchocerca volvulus | 0.0034 | 0.1201 | 0.6684 | |
Loa Loa (eye worm) | CXXC zinc finger family protein | 0.0028 | 0.0936 | 0.0936 |
Leishmania major | pyruvate dehydrogenase (lipoamide) kinase, putative | 0.0043 | 0.1614 | 0.3113 |
Echinococcus multilocularis | cpg binding protein | 0.0029 | 0.1006 | 0.1006 |
Echinococcus granulosus | Pyruvate dehydrogenase lipoamide kinase | 0.0123 | 0.5183 | 0.5183 |
Echinococcus multilocularis | BC026374 protein (S09 family) | 0.0034 | 0.1201 | 0.1201 |
Echinococcus multilocularis | Ataxin 2, N terminal,domain containing protein | 0.0011 | 0.0191 | 0.0191 |
Echinococcus granulosus | cadherin EGF LAG seven pass G type receptor | 0.0015 | 0.0387 | 0.0387 |
Echinococcus granulosus | histone lysine N methyltransferase MLL3 | 0.0007 | 0.0003 | 0.0003 |
Trichomonas vaginalis | carboxylesterase domain containing protein, putative | 0.0034 | 0.1201 | 1 |
Schistosoma mansoni | pyruvate dehydrogenase | 0.0116 | 0.4878 | 0.5667 |
Echinococcus multilocularis | histone lysine N methyltransferase MLL3 | 0.0009 | 0.0079 | 0.0079 |
Entamoeba histolytica | hypothetical protein | 0.0035 | 0.1249 | 1 |
Brugia malayi | hypothetical protein | 0.0025 | 0.0801 | 0.0801 |
Brugia malayi | kinase, mitochondrial precursor | 0.0123 | 0.5183 | 0.5183 |
Loa Loa (eye worm) | carboxylesterase | 0.0034 | 0.1201 | 0.1201 |
Schistosoma mansoni | pyruvate dehydrogenase | 0.0116 | 0.4878 | 0.5667 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Cmax (ADMET) | = 1 ug ml-1 | Cmax in mouse at 2 mg/kg, po | ChEMBL. | 19196509 |
ED50 (functional) | = 2 mg kg-1 | Antifungal activity against Candida albicans FP633 in po dosed ICR mouse candidiasis model treated after 1 hr post infection for 4 days | ChEMBL. | 19196509 |
MIC (functional) | = 0.25 ug ml-1 | Antifungal activity against Candida albicans FP290581 in ICR mouse serum drug administered po twice a day | ChEMBL. | 19196509 |
MIC (functional) | = 0.5 ug ml-1 | Antifungal activity against Candida albicans ATCC 90028 | ChEMBL. | 19196509 |
MIC (functional) | = 0.5 ug ml-1 | Antifungal activity against fluconazole-resistant Candida albicans 22009 | ChEMBL. | 19196509 |
MIC (functional) | = 4 ug ml-1 | Antifungal activity against Cryptococcus neoformans TIMM 0354 | ChEMBL. | 19196509 |
T1/2 (ADMET) | = 3.4 hr | Half life in mouse at 2 mg/kg, po | ChEMBL. | 19196509 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.